Status:

ACTIVE_NOT_RECRUITING

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

Lead Sponsor:

Abramson Cancer Center at Penn Medicine

Conditions:

Cardiotoxicity

Lung Cancer Stage III

Eligibility:

All Genders

18+ years

Brief Summary

This observational cohort will evaluate the cardiovascular effects of chemoradiation used to treat locally advanced, non-small cell lung cancer. Patients will be enrolled prior to the start of therapy...

Detailed Description

Lung cancer is both the most common malignancy worldwide and the leading cause of cancer death in the US. While radiation therapy is highly effective for many solid tumors, thoracic radiation therapy ...

Eligibility Criteria

Inclusion

  • At least 18 years of age
  • Histologically confirmed or clinically diagnosed non-small cell lung cancer where the plan is for definitive treatment that includes radiation
  • Able to give written informed consent

Exclusion

  • Pregnant or breast-feeding
  • Prior treatment with anthracyclines
  • Radiation treatment not expected to involve any heart exposure as determined by treating provider
  • ECOG performance status greater than 2
  • Vulnerable patients, including pregnant women and prisoners
  • Contraindication to rest/vasodilator stress PET/CT, including: asthma with ongoing wheezing at time of enrollment; known Mobitz Type II AV block, 3rd degree AV block, or sick sinus syndrom, without a pacemaker; systolic blood pressure less than 90mmHg; known hypersensitivity to Regadenoson and adenosine; profound sinus bradycardia (heart rate less than 40bpm).

Key Trial Info

Start Date :

September 14 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

221 Patients enrolled

Trial Details

Trial ID

NCT04305613

Start Date

September 14 2020

End Date

December 1 2030

Last Update

October 2 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

University of Alabama

Birmingham, Alabama, United States, 35233

2

The Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

3

Washington University School of Medicine

St Louis, Missouri, United States, 63110

4

Rutger's University / Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08901